The Use of Voxelotor for the Management of Sickle Cell Disease
In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.
- Shah N, Lipato T, Alvarez OA, et al. Real-world experience of voxelotor for the management of complications in sickle cell disease. Paper presented at: 63rd American Society of Hematology Annual Meeting & Exposition; December 11-13, 2021; Virtual. https://ash.confex.com/ash/2021/webprogram/Paper153138.html
Nirmish Shah, MD, is the director of the sickle cell transition program and the director of clinical research in benign hematology at Duke University School of Medicine (Durham, North Carolina).